19426200

Source:http://linkedlifedata.com/resource/pubmed/id/19426200

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0005839, umls-concept:C0450442, umls-concept:C0678861, umls-concept:C0680243, umls-concept:C0920762, umls-concept:C1883709, umls-concept:C1947901, umls-concept:C1948058
pubmed:issue	5
pubmed:dateCreated	2009-5-11
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19426200-19175548
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0417360
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Hematinics
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1537-2995
pubmed:author	pubmed-author:AdamsonJohn WJW
pubmed:issnType	Electronic
pubmed:volume	49
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	824-6
pubmed:meshHeading	pubmed-meshheading:19426200-Anemia, pubmed-meshheading:19426200-Hematinics, pubmed-meshheading:19426200-Humans, pubmed-meshheading:19426200-Neoplasms, pubmed-meshheading:19426200-Risk Assessment
pubmed:year	2009
pubmed:articleTitle	Erythropoietic-stimulating agents: the cancer progression controversy and collateral damage to the blood supply.
pubmed:publicationType	Editorial, Comment